Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy: A Single-Site Quality Improvement Pilot to Assess Attitudes and Access. Afezolli, D., Flemig, D., Easton, E., Austin, V., Scarborough, B., & Smith, C. B. Journal of Pain & Symptom Management, 65(4):e309–e314, April, 2023. doi abstract bibtex Limited data exist on when to offer naloxone to cancer patients on opioid therapy. We assessed patient and clinician attitudes on naloxone education (done via surveys at initial and follow up visits) and prescribing rates (via chart reviews) at a single ambulatory palliative care practice. Pharmacy records assessed naloxone dispense rates. During a three-month period, all new patients receiving opioid therapy were offered naloxone. Standardized educational materials on opioid safety and naloxone use were created and shared by clinical team. Naloxone prescribing rates increased from 5% to 66%. 92% (n = 23) of clinicians reported education/prescribing took ≤ five minutes, and 100% reported either a positive or neutral impact on the encounter. A total of 81% (n = 25) of patients reported no increased worry about opioid use, 68% (n = 21) felt safer with naloxone, and 97% rated the encounter as neutral or positive. 88% (n = 37) of prescriptions were dispensed and 67% of patients (n = 16) paid \textless$10. Opioid safety education and naloxone prescribing can be done quickly and is well-received by clinicians and patients.
@article{afezolli_standard_2023,
title = {Standard {Naloxone} {Prescribing} for {Palliative} {Care} {Cancer} {Patients} on {Opioid} {Therapy}: {A} {Single}-{Site} {Quality} {Improvement} {Pilot} to {Assess} {Attitudes} and {Access}},
volume = {65},
issn = {08853924},
shorttitle = {Standard {Naloxone} {Prescribing} for {Palliative} {Care} {Cancer} {Patients} on {Opioid} {Therapy}},
doi = {10.1016/j.jpainsymman.2022.12.014},
abstract = {Limited data exist on when to offer naloxone to cancer patients on opioid therapy. We assessed patient and clinician attitudes on naloxone education (done via surveys at initial and follow up visits) and prescribing rates (via chart reviews) at a single ambulatory palliative care practice. Pharmacy records assessed naloxone dispense rates. During a three-month period, all new patients receiving opioid therapy were offered naloxone. Standardized educational materials on opioid safety and naloxone use were created and shared by clinical team. Naloxone prescribing rates increased from 5\% to 66\%. 92\% (n = 23) of clinicians reported education/prescribing took ≤ five minutes, and 100\% reported either a positive or neutral impact on the encounter. A total of 81\% (n = 25) of patients reported no increased worry about opioid use, 68\% (n = 21) felt safer with naloxone, and 97\% rated the encounter as neutral or positive. 88\% (n = 37) of prescriptions were dispensed and 67\% of patients (n = 16) paid {\textless}\$10. Opioid safety education and naloxone prescribing can be done quickly and is well-received by clinicians and patients.},
number = {4},
journal = {Journal of Pain \& Symptom Management},
author = {Afezolli, Debora and Flemig, David and Easton, Eve and Austin, Vanessa and Scarborough, Bethann and Smith, Cardinale B.},
month = apr,
year = {2023},
keywords = {Naloxone, NALOXONE, PATIENTS' attitudes, DRUG prescribing, cancer pain, CANCER patient care, CHAPLAINS, opioid overdose prevention, opioid risk assessment, PALLIATIVE treatment, safe opioid prescribing, supportive oncology},
pages = {e309--e314},
}
Downloads: 0
{"_id":"qszbhnfP5pS2Y4hjP","bibbaseid":"afezolli-flemig-easton-austin-scarborough-smith-standardnaloxoneprescribingforpalliativecarecancerpatientsonopioidtherapyasinglesitequalityimprovementpilottoassessattitudesandaccess-2023","author_short":["Afezolli, D.","Flemig, D.","Easton, E.","Austin, V.","Scarborough, B.","Smith, C. B."],"bibdata":{"bibtype":"article","type":"article","title":"Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy: A Single-Site Quality Improvement Pilot to Assess Attitudes and Access","volume":"65","issn":"08853924","shorttitle":"Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy","doi":"10.1016/j.jpainsymman.2022.12.014","abstract":"Limited data exist on when to offer naloxone to cancer patients on opioid therapy. We assessed patient and clinician attitudes on naloxone education (done via surveys at initial and follow up visits) and prescribing rates (via chart reviews) at a single ambulatory palliative care practice. Pharmacy records assessed naloxone dispense rates. During a three-month period, all new patients receiving opioid therapy were offered naloxone. Standardized educational materials on opioid safety and naloxone use were created and shared by clinical team. Naloxone prescribing rates increased from 5% to 66%. 92% (n = 23) of clinicians reported education/prescribing took ≤ five minutes, and 100% reported either a positive or neutral impact on the encounter. A total of 81% (n = 25) of patients reported no increased worry about opioid use, 68% (n = 21) felt safer with naloxone, and 97% rated the encounter as neutral or positive. 88% (n = 37) of prescriptions were dispensed and 67% of patients (n = 16) paid \\textless$10. Opioid safety education and naloxone prescribing can be done quickly and is well-received by clinicians and patients.","number":"4","journal":"Journal of Pain & Symptom Management","author":[{"propositions":[],"lastnames":["Afezolli"],"firstnames":["Debora"],"suffixes":[]},{"propositions":[],"lastnames":["Flemig"],"firstnames":["David"],"suffixes":[]},{"propositions":[],"lastnames":["Easton"],"firstnames":["Eve"],"suffixes":[]},{"propositions":[],"lastnames":["Austin"],"firstnames":["Vanessa"],"suffixes":[]},{"propositions":[],"lastnames":["Scarborough"],"firstnames":["Bethann"],"suffixes":[]},{"propositions":[],"lastnames":["Smith"],"firstnames":["Cardinale","B."],"suffixes":[]}],"month":"April","year":"2023","keywords":"Naloxone, NALOXONE, PATIENTS' attitudes, DRUG prescribing, cancer pain, CANCER patient care, CHAPLAINS, opioid overdose prevention, opioid risk assessment, PALLIATIVE treatment, safe opioid prescribing, supportive oncology","pages":"e309–e314","bibtex":"@article{afezolli_standard_2023,\n\ttitle = {Standard {Naloxone} {Prescribing} for {Palliative} {Care} {Cancer} {Patients} on {Opioid} {Therapy}: {A} {Single}-{Site} {Quality} {Improvement} {Pilot} to {Assess} {Attitudes} and {Access}},\n\tvolume = {65},\n\tissn = {08853924},\n\tshorttitle = {Standard {Naloxone} {Prescribing} for {Palliative} {Care} {Cancer} {Patients} on {Opioid} {Therapy}},\n\tdoi = {10.1016/j.jpainsymman.2022.12.014},\n\tabstract = {Limited data exist on when to offer naloxone to cancer patients on opioid therapy. We assessed patient and clinician attitudes on naloxone education (done via surveys at initial and follow up visits) and prescribing rates (via chart reviews) at a single ambulatory palliative care practice. Pharmacy records assessed naloxone dispense rates. During a three-month period, all new patients receiving opioid therapy were offered naloxone. Standardized educational materials on opioid safety and naloxone use were created and shared by clinical team. Naloxone prescribing rates increased from 5\\% to 66\\%. 92\\% (n = 23) of clinicians reported education/prescribing took ≤ five minutes, and 100\\% reported either a positive or neutral impact on the encounter. A total of 81\\% (n = 25) of patients reported no increased worry about opioid use, 68\\% (n = 21) felt safer with naloxone, and 97\\% rated the encounter as neutral or positive. 88\\% (n = 37) of prescriptions were dispensed and 67\\% of patients (n = 16) paid {\\textless}\\$10. Opioid safety education and naloxone prescribing can be done quickly and is well-received by clinicians and patients.},\n\tnumber = {4},\n\tjournal = {Journal of Pain \\& Symptom Management},\n\tauthor = {Afezolli, Debora and Flemig, David and Easton, Eve and Austin, Vanessa and Scarborough, Bethann and Smith, Cardinale B.},\n\tmonth = apr,\n\tyear = {2023},\n\tkeywords = {Naloxone, NALOXONE, PATIENTS' attitudes, DRUG prescribing, cancer pain, CANCER patient care, CHAPLAINS, opioid overdose prevention, opioid risk assessment, PALLIATIVE treatment, safe opioid prescribing, supportive oncology},\n\tpages = {e309--e314},\n}\n\n","author_short":["Afezolli, D.","Flemig, D.","Easton, E.","Austin, V.","Scarborough, B.","Smith, C. B."],"key":"afezolli_standard_2023","id":"afezolli_standard_2023","bibbaseid":"afezolli-flemig-easton-austin-scarborough-smith-standardnaloxoneprescribingforpalliativecarecancerpatientsonopioidtherapyasinglesitequalityimprovementpilottoassessattitudesandaccess-2023","role":"author","urls":{},"keyword":["Naloxone","NALOXONE","PATIENTS' attitudes","DRUG prescribing","cancer pain","CANCER patient care","CHAPLAINS","opioid overdose prevention","opioid risk assessment","PALLIATIVE treatment","safe opioid prescribing","supportive oncology"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/f/A5QqTgyzt6xMGsfLu/export-data (2).bib","dataSources":["kRP2GSJ2YQiSr6jK7"],"keywords":["naloxone","naloxone","patients' attitudes","drug prescribing","cancer pain","cancer patient care","chaplains","opioid overdose prevention","opioid risk assessment","palliative treatment","safe opioid prescribing","supportive oncology"],"search_terms":["standard","naloxone","prescribing","palliative","care","cancer","patients","opioid","therapy","single","site","quality","improvement","pilot","assess","attitudes","access","afezolli","flemig","easton","austin","scarborough","smith"],"title":"Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy: A Single-Site Quality Improvement Pilot to Assess Attitudes and Access","year":2023}